Lorazepam
Product Images NDC 69189-4246

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Lorazepam (NDC 69189-4246). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Avera Mckennan Hospital, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Lorazepam 0.5 mg Tablet Label (6918942461)

Lorazepam 0.5 mg Tablet Label (6918942461)
Packaging label for Lorazepam 0.5 mg tablet from Avera McKennan Hospital. The label shows the manufacturer as Qualitest, includes lot numbers, an expiration date of 11/18/2016, and a National Drug Code (NDC) of 69189-4246. The product is classified as a Schedule C-IV controlled substance.*
FDA Label Image

Lorazepam 0.25 mg 1/2 Tablet Label (6918942465)

Lorazepam 0.25 mg 1/2 Tablet Label (6918942465)
Pharmaceutical label for Lorazepam 0.25 mg, stating it is half of a 0.5 mg tablet. The label lists manufacturer as Qualitest, with manufacturing lot number T122G15A and hospital lot number APF15K05-E. Expiration date is November 4, 2016. The product is classed as Schedule C-IV and labeled by Avera McKennan located in Sioux Falls, SD, with NDC 69189-42465.*
FDA Label Image

This Is An Image Of The Structural Formula For Lorazepam Tablets, Usp. (Loraz 1)

This Is An Image Of The Structural Formula For Lorazepam Tablets, Usp. (Loraz 1)
Chemical structure of Lorazepam showing its molecular formula C15H10Cl2N2O2 and molecular weight 321.16. The structure includes two chlorine atoms and various functional groups characteristic of the compound.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.